CORIXA CORP
10-Q, EX-3.3, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CORIXA CORP, 10-Q, 2000-08-14
Next: CORIXA CORP, 10-Q, EX-27.1, 2000-08-14



<PAGE>   1
                           CERTIFICATE OF AMENDMENT OF

                          CERTIFICATE OF INCORPORATION

                                       OF

                               CORIXA CORPORATION



        The undersigned hereby certifies that:

         1. She is the duly elected and acting Secretary of Corixa Corporation,
a Delaware corporation.

         2. The Certificate of Incorporation of this corporation was originally
filed with the Secretary of State of Delaware on September 8, 1994.

         3. Pursuant to Section 242 of the General Corporation Law of the State
of Delaware, this Certificate of Amendment of Certificate of Incorporation
amends the first paragraph of Article IV of this corporation's Certificate of
Incorporation to read in its entirety as follows:

            "This corporation is authorized to issue two classes of stock to be
designated common stock ("Common Stock") and preferred stock ("Preferred
Stock"). The total number of shares which the Corporation is authorized to issue
is One Hundred Ten Million (110,000,000) shares. The number of shares of Common
Stock authorized to be issued is One Hundred Million (100,000,000), par value
$0.001 per share, and the number of shares of Preferred Stock authorized to be
issued is Ten Million (10,000,000), par value $0.001 per share."

         4. The foregoing Certificate of Amendment has been duly adopted by this
corporation's Board of Directors and stockholders in accordance with the
applicable provisions of Section 242 of the General Corporation Law of the State
of Delaware.

         Executed at Seattle, Washington, June 1, 2000.



                                          /s/ KATHLEEN MCKEREGHAN
                                          ----------------------------------
                                          Kathleen McKereghan, Secretary



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission